BP000281-CHM-347: Recombinant Human MIP-1 α (CCL3), His Tag
Source: E. coli-derived.
Purity: > 95%, by RP-HPLC and SDS-PAGE.BP000281-CHM-320: Recombinant Mouse MIP-1 α (CCL3)
Source: E. coli-derived.
The activity is calculated by the ability to chemoattract of Balb3/C splenocytes using 1-10 ug/ml corresponding to a Specific Activity of 10,000-100,000 IU/mg.
Purity > 99%, by SDS-PAGE and RP-HPLC.BP000222-CYT-521: Recombinant Human Macrophage Migration Inhibitory Factor, His Tag C-Terminus
Source: E. coli-derived.
Measured by its ability to bind rhCD74 in a functional ELISA.
Purity > 95%, by SDS-PAGE and RP-HPLC.BP000222-CYT-431: Recombinant Human Macrophage Migration Inhibitory Factor, His Tag N-Terminus
Source: E. coli-derived.
Purity > 95%, by SDS-PAGE and RP-HPLC.BP000222-CYT-596: Recombinant Human Macrophage Migration Inhibitory Factor (Active)
Source: E. coli-derived.
Purity > 97%, by SDS-PAGE and RP-HPLC.BP000222-CYT-575: Recombinant Human Macrophage Migration Inhibitory Factor
Source: E. coli-derived.
Purity > 99%, by SDS-PAGE.BP000223-CYT-310: Recombinant Human Melanoma Inhibitory Activity Protein (MIA)
Source: E. coli-derived.
The biological activity is calculated by the inhibiting effect on the invasion of Mel In Tumor cells and found active in Mel In assay.
Purity: > 95% by SDS-PAGE and RP-HPLC.BP000279-CHM-250: Recombinant Human Macrophage-Derived Chemokine (CCL22)
Source: E. coli-derived.
A non-glycosylated, Polypeptide chain containing 69 amino acids and having a molecular mass of 8.1 kDa.
Determined by its ability to chemoattract human T cells using a concentration range of 10-100 ug/ml corresponding to a Specific Activity of 1,000-10,000 IU/mg.
Purity > 97%, by SDS-PAGE and RP-HPLC.BP000279-CHM-279: Recombinant Rat Macrophage-Derived Chemokine (CCL22)
Source: E. coli-derived.
Fully biologically active when compared to standard. Determined by its ability to chemoattract human activated lymphocytes using a concentration range of 10.0-100.0 ug/ml.
Purity > 97%, by SDS-PAGE and RP-HPLC.